Literature DB >> 32877833

Utility of PD-L1 testing on non-small cell lung cancer cytology specimens: An institutional experience with interobserver variability analysis.

Oleksandr Kravtsov1, Christopher P Hartley2, Yuri Sheinin3, Bryan C Hunt4, Juan C Felix5, Tamara Giorgadze6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32877833     DOI： 10.1016/j.anndiagpath.2020.151602

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN： 1092-9134            Impact factor:   2.090


× No keyword cloud information.
  2 in total

Review 1.  Program death ligand-1 immunocytochemistry in lung cancer cytological samples: A systematic review.

Authors:  Swati Satturwar; Ilaria Girolami; Enrico Munari; Francesco Ciompi; Albino Eccher; Liron Pantanowitz
Journal:  Diagn Cytopathol       Date:  2022-03-16       Impact factor: 1.390

Review 2.  PD-L1 and beyond: Immuno-oncology in cytopathology.

Authors:  Antonino Iaccarino; Maria Salatiello; Ilaria Migliatico; Caterina De Luca; Gianluca Gragnano; Maria Russo; Claudio Bellevicine; Umberto Malapelle; Giancarlo Troncone; Elena Vigliar
Journal:  Cytopathology       Date:  2021-05-06       Impact factor: 2.073
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.